WASHINGTON — Merck CEO Robert Davis and Johnson & Johnson CEO Joaquin Duato have agreed to voluntarily testify before the Senate health committee, avoiding a
Psyence Biomedical Ltd. (“Psyence Biomed”) is excited to announce the completion of its merger (the “Business Combination”) with Newcourt Acquisition Corp (“Newcourt”), a special purpose
PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and
This post is brought to you by R&A Psy-Ins, an insurance broker operating at the forefront of the psychedelics industry. Risk #1 General Liability Insurance
Globus Medical is laying off staff after the company merged with spine specialist Nuvasive. In California alone, the company is cutting more than 150 positions,
Joe Kiani, Masimo founder and CEO, has taken on one of the world’s largest companies and is not backing down in an intellectual property battle
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Cook Medical has sold a
Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of dollars for several drugmakers. But investment in experimental vaccines for
Share this article Patient-specific Organ Models Could Be Used To Minimize The Risk Of Side Effects And Provide Personalised Treatments. Credit: Elenabsl Via Shutterstock. In
Featured content in this Issue: Public and Industry Respond to DEA’s Renewed Plan to Place DOI and DOC in Schedule I Updates on State Psychedelics